Novo CEO pressed by Senate to cut rates of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers concerning the listing rates of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. Elevance lowers advice https://aya-healthcare-address28372.ezblogz.com/62279579/details-fiction-and-healthcare-news